The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for ...

The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the ...

Editas ended the third quarter with cash reserves of around $256 million, down from $318 million three months earlier. It ...

Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

While 2025 remains an unknown quantity, it’s clear that fundraisers and investors see the value in visiting London in ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...

As the healthcare landscape rapidly evolves, staying informed about emerging trends is crucial for driving innovation and ...

A new study has confirmed that the rate of colorectal cancer is rising in younger adults around the world, with England among ...

Overall, DoE is a valuable approach to improving the quality and efficacy of the final product, streamlining the process, and ...

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

"Offering Zepbound single-dose vials…through another platform to LillyDirect will help ensure broader availability of ...

Sports marketing offers healthcare brands an alternative channel to reach their audiences and align with the strong brand ...